Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
23S ribosomal RNA (23S rRNA) is a large, essential ribonucleic acid molecule that forms a core structural and functional component of the 50S large subunit of bacterial and archaeal ribosomes. It is approximately 2,904 nucleotides long in *Escherichia coli*. The primary function of the 23S rRNA is to form part of the peptidyl transferase center (PTC), which catalyzes peptide bond formation during protein synthesis—making it a true ribozyme. It provides binding sites for many antibiotics that inhibit translation by targeting this catalytic center or nearby regions. Mutations in specific domains can confer resistance to these antibiotics. A highly conserved sequence within domain V (ISR23) is specifically recognized by TLR13—a pattern recognition receptor—in some immune cells, enabling innate immune detection specific to bacteria.
Inhibition of peptidyl transferase activity; Blockage of nascent peptide exit tunnel; Disruption of ribosome function.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 23S Ribosomal RNA (Bacterial Large Ribosomal Subunit) (23S rRNA).